As of 2025-09-18, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (71.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.00 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -497.7%.
The range of the Relative Valuation is (56.12) - (94.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.5x - 11.5x | 8.0x |
| Forward P/E multiples | 6.8x - 12.1x | 9.4x |
| Fair Price | (56.12) - (94.68) | (71.58) |
| Upside | -411.8% - -626.0% | -497.7% |
| Date | P/E |
| 2025-09-16 | -2.15 |
| 2025-09-15 | -2.12 |
| 2025-09-12 | -1.98 |
| 2025-09-11 | -1.91 |
| 2025-09-10 | -1.72 |
| 2025-09-09 | -1.66 |
| 2025-09-08 | -1.62 |
| 2025-09-05 | -1.58 |
| 2025-09-04 | -1.55 |
| 2025-09-03 | -1.38 |
| 2025-09-02 | -1.45 |
| 2025-08-29 | -1.39 |
| 2025-08-28 | -1.40 |
| 2025-08-27 | -1.42 |
| 2025-08-26 | -1.38 |
| 2025-08-25 | -1.33 |
| 2025-08-22 | -1.38 |
| 2025-08-21 | -1.31 |
| 2025-08-20 | -1.26 |
| 2025-08-19 | -1.32 |
| 2025-08-18 | -1.43 |
| 2025-08-15 | -1.43 |
| 2025-08-14 | -1.37 |
| 2025-08-13 | -1.29 |
| 2025-08-12 | -1.33 |
| 2025-08-11 | -1.16 |
| 2025-08-08 | -1.20 |
| 2025-08-07 | -1.25 |
| 2025-08-06 | -1.22 |
| 2025-08-05 | -1.23 |
| 2025-08-04 | -1.31 |
| 2025-08-01 | -1.28 |
| 2025-07-31 | -1.32 |
| 2025-07-30 | -1.38 |
| 2025-07-29 | -1.41 |
| 2025-07-28 | -1.54 |
| 2025-07-25 | -1.62 |
| 2025-07-24 | -1.54 |
| 2025-07-23 | -1.70 |
| 2025-07-22 | -1.50 |
| 2025-07-21 | -1.43 |
| 2025-07-18 | -1.42 |
| 2025-07-17 | -1.25 |
| 2025-07-16 | -1.28 |
| 2025-07-15 | -1.29 |
| 2025-07-14 | -1.06 |
| 2025-07-11 | -1.03 |
| 2025-07-10 | -1.05 |
| 2025-07-09 | -1.03 |
| 2025-07-08 | -0.98 |